333 related articles for article (PubMed ID: 22406457)
1. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
[TBL] [Abstract][Full Text] [Related]
2. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.
Ivory CP; Chadee K
Infect Immun; 2007 Oct; 75(10):4917-22. PubMed ID: 17620349
[TBL] [Abstract][Full Text] [Related]
4. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828
[TBL] [Abstract][Full Text] [Related]
6. Natural infection of baboons by Entamoeba histolytica elicits anti- gal-lectin heavy subunit IgA and IgG antibodies with shared epitope specificity to that of humans.
Abd-Alla MD; Wolf RF; White GL; Kosanke SD; Carey DW; Verweij JJ; El-Dessouky YM; Zhang MJ; Ravdin JI
J Egypt Soc Parasitol; 2013 Dec; 43(3):723-35. PubMed ID: 24640872
[TBL] [Abstract][Full Text] [Related]
7. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
Roncolato EC; Teixeira JE; Barbosa JE; Zambelli Ramalho LN; Huston CD
Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
[TBL] [Abstract][Full Text] [Related]
8. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
Carrero JC; Contreras-Rojas A; Sánchez-Hernández B; Petrosyan P; Bobes RJ; Ortiz-Ortiz L; Laclette JP
Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
[TBL] [Abstract][Full Text] [Related]
9. Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.
Abhyankar MM; Noor Z; Tomai MA; Elvecrog J; Fox CB; Petri WA
Vaccine; 2017 Feb; 35(6):916-922. PubMed ID: 28089548
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response.
Abd-Alla MD; Jackson TF; Rogers T; Reddy S; Ravdin JI
Infect Immun; 2006 Jul; 74(7):3897-903. PubMed ID: 16790762
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests.
Haque R; Mollah NU; Ali IK; Alam K; Eubanks A; Lyerly D; Petri WA
J Clin Microbiol; 2000 Sep; 38(9):3235-9. PubMed ID: 10970364
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of heparan sulphate binding proteins of Entamoeba histolytica in a guinea pig model of intestinal amoebiasis.
Kaur U; Khurana S; Saikia UN; Dubey ML
Exp Parasitol; 2013 Nov; 135(3):486-96. PubMed ID: 24007700
[TBL] [Abstract][Full Text] [Related]
13. Optimizing a Multi-Component Intranasal
Abhyankar MM; Orr MT; Kinsey R; Sivananthan S; Nafziger AJ; Oakland DN; Young MK; Farr L; Uddin MJ; Leslie JL; Burgess SL; Liang H; De Lima I; Larson E; Guderian JA; Lin S; Kahn A; Ghosh P; Reed S; Tomai MA; Pedersen K; Petri WA; Fox CB
Front Immunol; 2021; 12():683157. PubMed ID: 34248966
[TBL] [Abstract][Full Text] [Related]
14. Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo.
Ivory CP; Chadee K
Eur J Immunol; 2007 Feb; 37(2):385-94. PubMed ID: 17219364
[TBL] [Abstract][Full Text] [Related]
15. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.
Ivory CP; Keller K; Chadee K
Infect Immun; 2006 Jan; 74(1):528-36. PubMed ID: 16369009
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.
Miller-Sims VC; Petri WA
Curr Opin Immunol; 2002 Oct; 14(5):549-52. PubMed ID: 12183151
[TBL] [Abstract][Full Text] [Related]
17. The future for vaccine development against Entamoeba histolytica.
Quach J; St-Pierre J; Chadee K
Hum Vaccin Immunother; 2014; 10(6):1514-21. PubMed ID: 24504133
[TBL] [Abstract][Full Text] [Related]
18. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis.
Lotter H; Zhang T; Seydel KB; Stanley SL; Tannich E
J Exp Med; 1997 May; 185(10):1793-801. PubMed ID: 9151705
[TBL] [Abstract][Full Text] [Related]
19. Progress towards development of a vaccine for amebiasis.
Stanley SL
Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666
[TBL] [Abstract][Full Text] [Related]
20. Prospect for an Entamoeba histolytica Gal-lectin-based vaccine.
Gaucher D; Chadee K
Parasite Immunol; 2003 Feb; 25(2):55-8. PubMed ID: 12791100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
